Optimal Timing of Hepatitis B Vaccination After Transplants

Clinical trial NCT06888479 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06888479
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Transplant-Related Disorder Hepatitis B Virus Infection Vaccine Reaction

Start date: 2025-06-01
Primary completion: 2028-06-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.